Fingerprint
Dive into the research topics where Lisa Geertjens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Potential benefits of l-serine in children with GRIN2B loss-of-function variants: Randomized n-of-1 trials
den Hollander, B., Rothuizen-Lindenschot, M., Le, H. L., Ramautar, J. R., Müller, A. R., Geertjens, L., Vaz, F. M., van Eeghen, A. M., Cornel, M. C., Jacobs, B. A. W., Bruining, H., van de Ven, P. M., Brands, M. M. & van Karnebeek, C. D., Dec 2025, In: Molecular genetics and metabolism. 146, 4, p. 109268 109268.Research output: Contribution to journal › Article › Academic › peer-review
-
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials
Müller, A. R., den Hollander, B., van de Ven, P. M., Roes, K. C. B., Geertjens, L., Bruining, H., van Karnebeek, C. D. M., Jansen, F. E., de Wit, M. C. Y., Ten Hoopen, L. W., Rietman, A. B., Dierckx, B., Wijburg, F. A., Boot, E., Brands, M. M. G. & van Eeghen, A. M., 1 Dec 2024, In: BMC psychiatry. 24, 1, p. 23 23.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile30 Downloads (Pure) -
Corrigendum to “Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials” [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233] (Contemporary Clinical Trials Communications (2023) 36, (S2451865423001795), (10.1016/j.conctc.2023.101233))
Hollander, B. D., Rothuizen-Lindenschot, M., Geertjens, L., Vaz, F. M., Brands, M. M., le, H. L., van Eeghen, A. M., van de Ven, P. M., Cornel, M. C., Jacobs, B. A. W., Bruining, H. & van Karnebeek, C. D., Apr 2024, In: Contemporary Clinical Trials Communications. 38, p. 101264 101264.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile21 Downloads (Pure) -
Mechanism-based interventions for ASD cannot be implemented using conventional trial designs
Sprengers, J. J., Geertjens, L. & Bruining, H., Feb 2024, In: Autism research. 17, 2, p. 202-203 2 p.Research output: Contribution to journal › Letter › Academic › peer-review
Open AccessFile38 Downloads (Pure) -
Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials.
den Hollander, B., Rothuizen-Lindenschot, M., Geertjens, L., Vaz, F. M., Brands, M. M., le, H. L., van Eeghen, A. M., van de Ven, P. M., Cornel, M. C., Jacobs, B. A. W., Bruining, H. & van Karnebeek, C. D., 1 Dec 2023, In: Contemporary Clinical Trials Communications. 36, p. 101233 101233.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile18 Downloads (Pure)